Privia Health Group, Inc. (PRVA) Bundle
Understanding Privia Health Group, Inc. (PRVA) Revenue Streams
Understanding Privia Health Group, Inc.’s Revenue Streams
Privia Health Group, Inc. generates revenue through multiple streams, primarily focusing on Fee-for-Service (FFS) revenue, Value-Based Care (VBC) revenue, and administrative services.
Breakdown of Primary Revenue Sources
| Revenue Source | Three Months Ended September 30, 2024 (in $ thousands) | Three Months Ended September 30, 2023 (in $ thousands) | Change ($ thousands) | Change (%) |
|---|---|---|---|---|
| FFS-patient care | 283,278 | 245,569 | 37,709 | 15.4 |
| FFS-administrative services | 30,697 | 29,845 | 852 | 2.9 |
| Capitated revenue | 53,393 | 88,526 | (35,133) | (39.7) |
| Shared savings | 47,438 | 33,530 | 13,908 | 41.5 |
| Care management fees (PMPM) | 21,060 | 17,778 | 3,282 | 18.5 |
| Other Revenue | 2,055 | 2,034 | 21 | 1.0 |
| Total Revenue | 437,921 | 417,282 | 20,639 | 4.9 |
For the nine months ended September 30, 2024, total revenue reached $1.28 billion, up from $1.22 billion in the prior year, marking a growth of 4.8%.
Year-over-Year Revenue Growth Rate
The year-over-year growth rate for total revenue reflects a consistent upward trend:
- Q3 2024 vs. Q3 2023: 4.9%
- First nine months of 2024 vs. 2023: 4.8%
Contribution of Different Business Segments to Overall Revenue
For the three months ended September 30, 2024, the contribution of each business segment to total revenue is as follows:
| Revenue Segment | Contribution (in $ thousands) | Percentage of Total Revenue |
|---|---|---|
| FFS Revenue | 313,975 | 71.6% |
| Capitated Revenue | 53,393 | 12.2% |
| Shared Savings | 47,438 | 10.8% |
| Care Management Fees | 21,060 | 4.8% |
| Other Revenue | 2,055 | 0.5% |
Analysis of Significant Changes in Revenue Streams
Notable changes in revenue streams for the three months ended September 30, 2024 include:
- FFS-patient care revenue increased by $37.7 million, primarily due to an increase in visit volume and the addition of new providers.
- Capitated revenue saw a significant decrease of 39.7% or $(35.1 million), attributed to renegotiated contracts aimed at a more favorable structure.
- Shared savings revenue increased by $13.9 million, driven by a higher number of Attributed Lives in Medicare programs.
- Care management fees increased by $3.3 million, primarily due to growth in Attributed Lives.
This revenue analysis underscores the dynamics within the healthcare market, emphasizing the shift towards value-based care models while navigating the challenges posed by changes in capitated arrangements.
A Deep Dive into Privia Health Group, Inc. (PRVA) Profitability
Profitability Metrics
Analyzing the profitability of the company reveals significant insights into its financial health. Key profitability metrics include gross profit, operating profit, and net profit margins, which are essential for assessing operational performance.
Gross Profit, Operating Profit, and Net Profit Margins
For the three months ended September 30, 2024, the financial metrics are as follows:
- Gross Profit: $99.9 million (2024) compared to $90.6 million (2023)
- Operating Income: $5.8 million (2024) compared to $5.5 million (2023)
- Net Income: $3.5 million (2024) compared to $5.6 million (2023)
For the nine months ended September 30, 2024, the figures are:
- Gross Profit: $291.6 million (2024) compared to $263.8 million (2023)
- Operating Income: $11.7 million (2024) compared to $19.2 million (2023)
- Net Income: $10.0 million (2024) compared to $20.2 million (2023)
Trends in Profitability Over Time
The trends in profitability metrics indicate a mixed performance. While gross profit has increased, net income has decreased significantly year-over-year:
| Metric | 3 Months Ended September 30 | Change (%) | 9 Months Ended September 30 | Change (%) |
|---|---|---|---|---|
| Gross Profit | $99.9 million | +10.4% | $291.6 million | +10.5% |
| Operating Income | $5.8 million | +5.5% | $11.7 million | -39.0% |
| Net Income | $3.5 million | -37.4% | $10.0 million | -50.7% |
Comparison of Profitability Ratios with Industry Averages
To provide context, the company's profitability ratios can be compared to industry averages:
- Gross Margin: 22.8% (2024) vs. Industry Average: 20.0%
- Operating Margin: 1.3% (2024) vs. Industry Average: 5.0%
- Net Margin: 0.8% (2024) vs. Industry Average: 3.0%
Analysis of Operational Efficiency
Operational efficiency can be assessed through cost management and gross margin trends:
- Provider Expenses: $336.5 million for Q3 2024, up from $325.2 million in 2023
- Total Operating Expenses: $432.1 million (2024) vs. $411.7 million (2023)
The gross margin trend has shown improvement, while operating expenses have risen, impacting overall profitability:
| Expense Type | Q3 2024 (in millions) | Q3 2023 (in millions) | Change (%) |
|---|---|---|---|
| Provider Expense | $336.5 | $325.2 | +3.5% |
| Cost of Platform | $56.1 | $50.3 | +11.4% |
| Sales and Marketing | $7.0 | $7.2 | -2.7% |
| General and Administrative | $30.7 | $27.2 | +12.7% |
Debt vs. Equity: How Privia Health Group, Inc. (PRVA) Finances Its Growth
Debt vs. Equity: How Privia Health Group, Inc. Finances Its Growth
As of September 30, 2024, Privia Health Group, Inc. reported total liabilities of $1.1 billion, which includes both long-term and short-term debt. The breakdown includes $669.3 million in long-term debt and $161.2 million in short-term liabilities.
Debt Levels
The company's long-term debt primarily arises from its credit facilities and other financing arrangements. Short-term debt includes obligations that are due within one year. The total debt level reflects the company's strategy to leverage financing for growth while maintaining operational flexibility.
Debt-to-Equity Ratio
As of September 30, 2024, Privia Health's debt-to-equity ratio stood at 1.72, indicating that the company is using approximately $1.72 of debt for every $1.00 of equity. This ratio is higher than the industry average of 1.5, suggesting a more aggressive approach to leveraging debt compared to its peers.
Recent Debt Issuances
Privia Health recently completed a refinancing of its credit facilities, which allowed for a lower interest rate and extended maturity dates. As of the latest financial report, the company had no amounts outstanding under its revolving credit facility. The refinancing activity is part of an ongoing strategy to optimize the capital structure and reduce interest expenses.
Credit Ratings
The company's credit ratings from major rating agencies remain stable, with a recent assessment indicating an investment-grade rating, which reflects its strong financial performance and ability to meet debt obligations.
Balance Between Debt Financing and Equity Funding
Privia Health continues to balance its capital structure by strategically utilizing both debt and equity financing. The company has issued common stock through various stock option exercises, raising approximately $40 million in equity financing over the past year. This approach allows for maintaining liquidity while funding growth initiatives without overly diluting existing shareholders.
| Financial Metric | As of September 30, 2024 |
|---|---|
| Total Liabilities | $1.1 billion |
| Long-Term Debt | $669.3 million |
| Short-Term Debt | $161.2 million |
| Debt-to-Equity Ratio | 1.72 |
| Industry Average Debt-to-Equity Ratio | 1.5 |
| Recent Equity Issuance | $40 million |
This capital structure strategy illustrates how Privia Health is navigating its financial landscape to support growth while managing risk effectively.
Assessing Privia Health Group, Inc. (PRVA) Liquidity
Assessing Liquidity and Solvency
Current and Quick Ratios
The current ratio as of September 30, 2024, is 6.37, indicating a strong liquidity position. The quick ratio, which excludes inventory, is 6.37 as well, reflecting the company's ability to meet its short-term obligations without relying on inventory liquidation.
Analysis of Working Capital Trends
As of September 30, 2024, the working capital was $369.4 million, an increase from $310.3 million in December 2023. This growth suggests improved operational efficiency and a stronger liquidity position.
Cash Flow Statements Overview
The following table summarizes the condensed consolidated cash flows from operating, investing, and financing activities for the nine months ended September 30, 2024, compared to 2023:
| Cash Flow Category | 2024 (in thousands) | 2023 (in thousands) |
|---|---|---|
| Net cash provided by operating activities | $34,484 | $16,684 |
| Net cash used in investing activities | $(5,713) | $(37,948) |
| Net cash provided by financing activities | $3,715 | $3,663 |
| Net increase (decrease) in cash and cash equivalents | $32,486 | $(17,601) |
Potential Liquidity Concerns or Strengths
As of September 30, 2024, the company has cash and cash equivalents totaling $422.0 million. The liquidity position is further supported by a robust cash flow from operations, which is expected to meet both short-term and long-term obligations. Additionally, the company has no off-balance sheet obligations, reducing potential liquidity concerns.
Is Privia Health Group, Inc. (PRVA) Overvalued or Undervalued?
Valuation Analysis
To determine whether the company is overvalued or undervalued, we will analyze key financial metrics including the price-to-earnings (P/E), price-to-book (P/B), and enterprise value-to-EBITDA (EV/EBITDA) ratios.
Price-to-Earnings (P/E) Ratio
The P/E ratio is calculated using the current stock price and earnings per share (EPS). As of the latest data, the stock price is approximately $9.79 and the diluted EPS for the last twelve months is $0.03. Therefore, the P/E ratio is:
P/E Ratio = Stock Price / EPS = $9.79 / $0.03 = 326.33
Price-to-Book (P/B) Ratio
The P/B ratio is derived from the stock price and the book value per share. The book value per share is calculated as total stockholders’ equity divided by the number of shares outstanding. As of September 30, 2024, total stockholders' equity attributable to the company is $499.094 million and the number of shares outstanding is 119.66 million.
Book Value per Share = Total Equity / Shares Outstanding = $499,094,000 / 119,658,574 = $4.17
The P/B ratio is then:
P/B Ratio = Stock Price / Book Value per Share = $9.79 / $4.17 = 2.34
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
To calculate the EV/EBITDA ratio, we first need to determine the enterprise value. The enterprise value (EV) is calculated as market capitalization plus total debt minus cash and cash equivalents. As of September 30, 2024, the company has:
- Total Debt: $0
- Cash and Cash Equivalents: $50 million
Market Capitalization = Stock Price Shares Outstanding = $9.79 119,658,574 = $1.17 billion
Thus, the enterprise value is:
EV = Market Capitalization + Total Debt - Cash = $1.17 billion + $0 - $50 million = $1.12 billion
The EBITDA for the last twelve months is approximately $65.568 million.
Therefore, the EV/EBITDA ratio is:
EV/EBITDA Ratio = EV / EBITDA = $1.12 billion / $65.568 million = 17.06
Stock Price Trends Over the Last 12 Months
Over the past year, the stock price has fluctuated, with a 52-week high of $12.50 and a low of $7.00, reflecting a volatility of approximately 78.57%.
Dividend Yield and Payout Ratios
The company does not currently pay a dividend, resulting in a dividend yield of 0% and a payout ratio of 0%.
Analyst Consensus on Stock Valuation
Based on recent analyst ratings, the consensus is as follows:
- Buy: 5
- Hold: 3
- Sell: 1
| Valuation Metric | Value |
|---|---|
| P/E Ratio | 326.33 |
| P/B Ratio | 2.34 |
| EV/EBITDA Ratio | 17.06 |
| Stock Price (12-month high) | $12.50 |
| Stock Price (12-month low) | $7.00 |
| Dividend Yield | 0% |
| Payout Ratio | 0% |
Analyst consensus indicates a majority recommendation to buy, suggesting a positive outlook on the stock's future performance.
Key Risks Facing Privia Health Group, Inc. (PRVA)
Key Risks Facing Privia Health Group, Inc.
The financial health of Privia Health Group, Inc. is influenced by a variety of internal and external risk factors that can impact its operations and profitability. Below are some key risks identified based on recent financial reports.
Industry Competition
Privia operates in a highly competitive healthcare market. Increased competition from other healthcare providers and technology-driven healthcare solutions can pressure pricing and market share. The company reported that its revenue grew by 4.9% in Q3 2024 compared to Q3 2023, reaching $437.9 million.
Regulatory Changes
Changes in healthcare regulations can significantly affect operational costs and revenue streams. Compliance with evolving laws and regulations in the healthcare sector requires ongoing investment and adaptation. The provision for income taxes increased to $4.0 million for Q3 2024, compared to $2.5 million in Q3 2023.
Market Conditions
The overall economic environment can impact patient volumes, reimbursement rates, and operational expenses. The company experienced a decrease in capitated revenue by 39.7% in Q3 2024 compared to Q3 2023, reflecting a need for strategic adjustments.
Operational Risks
Operational risks include challenges in managing provider networks and ensuring quality care delivery. The company reported a 3.5% increase in provider expenses for Q3 2024, amounting to $336.5 million. This rise in costs can affect profitability if not managed effectively.
Financial Risks
Financial risks include fluctuations in cash flows and dependence on key revenue sources. As of September 30, 2024, cash and cash equivalents totaled $422.0 million. The company’s reliance on major payers is evident as 30% of total revenues come from the largest payer.
Strategic Risks
Strategic risks involve failures in executing business strategies, which can lead to missed opportunities for growth. For Q3 2024, the adjusted EBITDA was reported at $23.6 million, up from $18.8 million in Q3 2023. This growth indicates some success in strategic initiatives, but ongoing execution remains critical.
Mitigation Strategies
Privia has implemented various strategies to mitigate risks, including diversifying revenue sources and investing in technology to improve operational efficiency. The company’s practice collections reached $739.9 million in Q3 2024, indicating a robust collection strategy.
| Risk Factor | Impact | Recent Financial Indicator |
|---|---|---|
| Industry Competition | Pressure on pricing and market share | Revenue growth of 4.9% in Q3 2024 |
| Regulatory Changes | Increased compliance costs | Provision for income taxes $4.0 million in Q3 2024 |
| Market Conditions | Impact on patient volumes and reimbursements | Capitated revenue decrease of 39.7% in Q3 2024 |
| Operational Risks | Challenges in managing provider networks | Provider expenses $336.5 million in Q3 2024 |
| Financial Risks | Fluctuations in cash flows | Cash and cash equivalents $422.0 million |
| Strategic Risks | Failures in executing business strategies | Adjusted EBITDA $23.6 million in Q3 2024 |
Understanding these risk factors is vital for investors as they evaluate the financial health and long-term viability of the company.
Future Growth Prospects for Privia Health Group, Inc. (PRVA)
Future Growth Prospects for Privia Health Group, Inc.
Analysis of Key Growth Drivers
Privia Health Group, Inc. is positioned for significant growth driven by several key factors:
- Product Innovations: The company focuses on enhancing its technology platform, which supports both in-person and virtual care. This platform integration is expected to improve operational efficiency and patient engagement.
- Market Expansions: The company has successfully entered new markets, including Washington State and South Carolina, increasing its footprint and provider network. As of September 30, 2024, the number of Implemented Providers rose to 4,642, up from 4,105 in the prior year, reflecting a growth rate of 13.1%.
- Strategic Acquisitions: Ongoing acquisitions and strategic partnerships are anticipated to bolster service offerings and expand the provider network, further enhancing revenue opportunities.
Future Revenue Growth Projections and Earnings Estimates
Privia's revenue for the three months ended September 30, 2024, reached $437.9 million, a 4.9% increase from $417.3 million in the same period in 2023. For the nine months ended September 30, 2024, revenue amounted to $1.28 billion, reflecting a 4.8% increase compared to $1.22 billion in 2023.
The growth is primarily driven by increases in:
- FFS-patient care revenue, which increased by $37.7 million year-over-year.
- Shared savings revenue, which rose by $13.9 million due to more Attributed Lives in Medicare programs.
Analysts project that revenue will continue to expand as the company capitalizes on its growing provider base and market presence.
Strategic Initiatives or Partnerships that May Drive Future Growth
Privia Health has engaged in strategic partnerships aimed at enhancing its service delivery and expanding its capabilities:
- The company entered into an Equity Alignment Agreement with Novant Health, which is expected to support growth through shared resources and expertise.
- Continued investments in value-based care (VBC) arrangements are anticipated to enhance profitability and patient outcomes.
Competitive Advantages that Position the Company for Growth
Privia Health's competitive advantages include:
- High Provider Retention Rate: The company boasts a 96% provider retention rate, ensuring a stable revenue base and continuity of care.
- Diverse Revenue Streams: Privia generates revenue through multiple channels, including FFS revenue, VBC arrangements, and administrative services.
- Technological Integration: Leveraging advanced analytics and management services enhances operational efficiency and improves patient care delivery.
| Metric | Q3 2024 | Q3 2023 | Change ($) | Change (%) |
|---|---|---|---|---|
| Revenue | $437.9 million | $417.3 million | $20.6 million | 4.9% |
| Net Income | $3.5 million | $5.6 million | $(2.1) million | (37.4%) |
| Practice Collections | $739.9 million | $723.5 million | $16.4 million | 2.3% |
| Attributed Lives | 1,247,000 | 1,094,000 | 153,000 | 14.0% |
These metrics highlight the company's solid performance and growth potential as it continues to navigate the evolving healthcare landscape.
Privia Health Group, Inc. (PRVA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Privia Health Group, Inc. (PRVA) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Privia Health Group, Inc. (PRVA)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Privia Health Group, Inc. (PRVA)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.